Doctor profile · Federal record
Dr. Sharad Lakhanpal, M.D.
Rheumatology Physician (CMS: Internal Medicine) · Specialist · Dallas, TX
- NPI 1720087414
- Accepts Medicare
- MIPS 38.0 / 100 · 2023
- 52 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
8144 Walnut Hill Ln, Suite 800
Dallas, TX 752314388
(214) 540-0700
fax (214) 540-0701 - Mailing address
-
8144 Walnut Hill Ln Ste 800
Dallas, TX 752314345
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- January 31, 2025
- Year of graduation
- 1974 — 52 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Texas #H1610
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720087414. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
160,222
Distinct HCPCS
10
Medicare allowed
$1,101,739
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 145,600 | 40 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 2,700 | 26 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,172 | 327 | $128 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,151 | 339 | $7 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,150 | 340 | $8 | |
85652 |
Red blood cell sedimentation rate, to detect inflammation, automated | 1,145 | 341 | $3 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 1,142 | 341 | $5 | |
80053 |
Blood test, comprehensive group of blood chemicals | 1,141 | 339 | $10 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 768 | 65 | $74 | |
81003 |
Automated urinalysis test | 590 | 244 | $2 |
In context: peer comparison
Among 15 peers in Dallas Rheumatology Physician, average services per provider: 1,860. This provider delivers 86× the peer median.Open Payments
Industry payments received
All-time total
$10,302
Transactions
19
Manufacturers
6
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 11 | $10,135.82 | |
| GlaxoSmithKline, LLC. | 2 | $43.81 | |
| Pfizer INC. | 2 | $42.00 | |
| Kiniksa Pharmaceuticals International, Plc | 1 | $30.81 | |
| Novartis Pharmaceuticals Corporation | 2 | $30.15 | |
| Amgen INC. | 1 | $19.36 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,059
Patients
850
Total drug cost
$692,234
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 246 | 98 | $20,759 |
| Meloxicam | Generic | 208 | 97 | $1,258 |
| Cyclobenzaprine Hcl | Generic | 200 | 107 | $1,976 |
| Methotrexate (Methotrexate Sodium) | Brand | 186 | 72 | $6,366 |
| Celecoxib | Generic | 179 | 74 | $10,038 |
| Vitamin D2 (Ergocalciferol (Vitamin D2)) | Brand | 179 | 94 | $1,946 |
| Sulfasalazine | Generic | 168 | 57 | $4,581 |
| Etodolac | Generic | 129 | 56 | $8,148 |
| Leflunomide | Generic | 127 | 43 | $7,162 |
| Tizanidine Hcl | Generic | 103 | 57 | $895 |
Frequently asked questions
What is Dr. Sharad Lakhanpal's medical specialty?
Dr. Sharad Lakhanpal practices Rheumatology Physician in Dallas, TX.
Where does Dr. Sharad Lakhanpal practice?
Dr. Sharad Lakhanpal practices at 8144 Walnut Hill Ln, Dallas, TX 752314388. Office phone: 2145400700.
What is Dr. Sharad Lakhanpal's NPI?
Dr. Sharad Lakhanpal's National Provider Identifier (NPI) is 1720087414, issued by NPPES.
Does Dr. Sharad Lakhanpal accept Medicare assignment?
Yes. Dr. Sharad Lakhanpal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sharad Lakhanpal commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.